Safe use of a once‐a‐week glucagon‐like peptide‐1 receptor agonist in a 16‐year‐old girl with type 2 diabetes when approved therapy options fail

Safe use of a once‐a‐week glucagon‐like peptide‐1 receptor agonist in a 16‐year‐old girl with type 2 diabetes when approved therapy options fail

Abstract This case report demonstrates that using a non‐approved long‐acting GLP‐1‐RA (dulaglutide) in adolescents with T2D is possible and feasible under special circumstances when approved therapeutic options for the pediatric population fail to achieve adequate glycemic control.

Bibliographic Details
Main Authors: Louisa van denBoom, Theresa Stuecher, Julia K. Mader
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Clinical Case Reports
Subjects:
adolescents
dulaglutide
type 2 diabetes
Online Access:https://doi.org/10.1002/ccr3.4811
id doaj-fc5e5e3538bf4690aad9d2506ea3049b
record_format Article
spelling doaj-fc5e5e3538bf4690aad9d2506ea3049b2021-09-27T07:16:17ZengWileyClinical Case Reports2050-09042021-09-0199n/an/a10.1002/ccr3.4811Safe use of a once‐a‐week glucagon‐like peptide‐1 receptor agonist in a 16‐year‐old girl with type 2 diabetes when approved therapy options failLouisa van denBoom0Theresa Stuecher1Julia K. Mader2Division of Pediatrics DRK Hospital Kirchen Kirchen GermanyDivision of Pediatrics DRK‐Kinderklinik Siegen gGmbH Siegen GermanyDivision of Pediatrics DRK Hospital Kirchen Kirchen GermanyAbstract This case report demonstrates that using a non‐approved long‐acting GLP‐1‐RA (dulaglutide) in adolescents with T2D is possible and feasible under special circumstances when approved therapeutic options for the pediatric population fail to achieve adequate glycemic control.https://doi.org/10.1002/ccr3.4811adolescentsdulaglutidetype 2 diabetes
collection DOAJ
language English
format Article
sources DOAJ
author Louisa van denBoom
Theresa Stuecher
Julia K. Mader
spellingShingle Louisa van denBoom
Theresa Stuecher
Julia K. Mader
Safe use of a once‐a‐week glucagon‐like peptide‐1 receptor agonist in a 16‐year‐old girl with type 2 diabetes when approved therapy options fail
Clinical Case Reports
adolescents
dulaglutide
type 2 diabetes
author_facet Louisa van denBoom
Theresa Stuecher
Julia K. Mader
author_sort Louisa van denBoom
title Safe use of a once‐a‐week glucagon‐like peptide‐1 receptor agonist in a 16‐year‐old girl with type 2 diabetes when approved therapy options fail
title_short Safe use of a once‐a‐week glucagon‐like peptide‐1 receptor agonist in a 16‐year‐old girl with type 2 diabetes when approved therapy options fail
title_full Safe use of a once‐a‐week glucagon‐like peptide‐1 receptor agonist in a 16‐year‐old girl with type 2 diabetes when approved therapy options fail
title_fullStr Safe use of a once‐a‐week glucagon‐like peptide‐1 receptor agonist in a 16‐year‐old girl with type 2 diabetes when approved therapy options fail
title_full_unstemmed Safe use of a once‐a‐week glucagon‐like peptide‐1 receptor agonist in a 16‐year‐old girl with type 2 diabetes when approved therapy options fail
title_sort safe use of a once‐a‐week glucagon‐like peptide‐1 receptor agonist in a 16‐year‐old girl with type 2 diabetes when approved therapy options fail
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2021-09-01
description Abstract This case report demonstrates that using a non‐approved long‐acting GLP‐1‐RA (dulaglutide) in adolescents with T2D is possible and feasible under special circumstances when approved therapeutic options for the pediatric population fail to achieve adequate glycemic control.
topic adolescents
dulaglutide
type 2 diabetes
url https://doi.org/10.1002/ccr3.4811
work_keys_str_mv AT louisavandenboom safeuseofaonceaweekglucagonlikepeptide1receptoragonistina16yearoldgirlwithtype2diabeteswhenapprovedtherapyoptionsfail
AT theresastuecher safeuseofaonceaweekglucagonlikepeptide1receptoragonistina16yearoldgirlwithtype2diabeteswhenapprovedtherapyoptionsfail
AT juliakmader safeuseofaonceaweekglucagonlikepeptide1receptoragonistina16yearoldgirlwithtype2diabeteswhenapprovedtherapyoptionsfail
_version_ 1716867060169965568

Similar Items